Utility of blood tests in screening for metabolic disorders in kidney stone disease
Open Access
- 23 September 2020
- journal article
- editorial
- Published by Wiley in BJU International
- Vol. 127 (5) , 538-543
Abstract
Objectives: To determine the clinical utility of blood tests as a screening tool for metabolic abnormalities in patients with kidney stone disease. Subjects and Methods: Clinical and biochemical data from 709 patients attending the Oxford University Hospitals NHS Foundation Trust for assessment and treatment of kidney stones were prospectively collected between April 2011 and February 2017. Data were analysed to determine the utility of serum calcium, parathyroid hormone (PTH), urate, chloride, bicarbonate, potassium and phosphate assays in screening for primary hyperparathyroidism, normocalcaemic hyperparathyroidism, hyperuricosuria, distal renal tubular acidosis (dRTA) and hypercalciuria. Results: An elevated serum calcium level was detected in 2.3% of patients. Further investigations prompted by this finding resulted in a diagnosis of primary hyperparathyroidism in 0.2% of men and 4.6% of women for whom serum calcium was recorded. An elevated serum PTH level in the absence of hypercalcaemia was detected in 15.1% of patients. Of these patients, 74.6% were vitamin D‐insufficient; no patients were diagnosed with normocalcaemic hyperparathyroidism. Hyperuricosuria was present in 21.6% of patients and hypercalciuria in 47.1%. Hyperuricaemia was not associated with hyperuricosuria, nor was hypophosphataemia associated with hypercalciuria. No patient was highlighted as being at risk of dRTA using serum chloride and bicarbonate as screening tests. Conclusion: This study indicates that individuals presenting with renal calculi should undergo metabolic screening with a serum calcium measurement alone. Use of additional blood tests to screen for metabolic disorders is not cost‐effective and may provide false reassurance that metabolic abnormalities are not present. A full metabolic assessment with 24‐h urine collection should be undertaken in recurrent stone formers and in those at high risk of future stone disease to identify potentially treatable metabolic abnormalities.Keywords
Funding Information
- National Institute for Health Research Oxford Biomedical Research Centre
This publication has 34 references indexed in Scilit:
- Prevalence of Kidney Stones in the United StatesEuropean Urology, 2012
- Higher serum bicarbonate levels within the normal range are associated with better survival and renal outcomes in African AmericansKidney International, 2011
- NephrolithiasisPrimary Care: Clinics in Office Practice, 2008
- Kidney stone diseaseJournal of Clinical Investigation, 2005
- Bone histology and bone mineral density after correction of acidosis in distal renal tubular acidosisKidney International, 2002
- Frequency of renal phosphate leak among patients with calcium nephrolithiasisKidney International, 2001
- Meta-Analysis of Randomized Trials for Medical Prevention of Calcium Oxalate NephrolithiasisJournal of Endourology, 1999
- Randomized Trial of Allopurinol in the Prevention of Calcium Oxalate CalculiNew England Journal of Medicine, 1986
- Prevention of calcium nephrolithiasis with low-dose thiazide, amiloride and allopurinolThe American Journal of Medicine, 1981
- Ambulatory evaluation of nephrolithiasisThe American Journal of Medicine, 1980